Indian Journal of Public Health Research & Development

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Comparative Study of the Therapeutic Efficacy of the Dapsone (Alone), Dapsone Plus Tacrolimus (Topical) and Dapsone Plus Triamcinolone (Topical) in Oral Lichen Planus


Affiliations
1 Department of Dermatology, Santosh Medical College, Ghaziabad (UP), India
2 Department of Microbiology, Santosh Medical College, Ghaziabad (UP), India
     

   Subscribe/Renew Journal


Background: Oral lichen planus (OLP) is a common, chronic inflammatory condition, which frequently present with symptoms of pain and irritation. OLP is difficult to manage. Existing clinical trials have shown that oral Dapsone and topical corticosteroids are often effective in the management of OLP. However, Tacrolimus has recently been shown to be an effective treatment of OLP without any side effects.

Objective: The purpose of this study was to compare the efficacy and safety of Dapsone (alone), Dapsone + Tacrolimus (topical) and Dapsone +Triamcinolone (topical) in management of OLP. Material and Method: In this randomized comparative double-blind study, 57 patients with oral lesions consistent clinically and histologically with OLP were recruited. Patients were divided into three groups of 17 and 22 & 18. In group-1, 17 patients were given oral Dapsone alone. In group-2, 22 patients were given oral Dapsone and topical Tacrolimus (0.1%).while in group 3, 18 patients were given oral Dapsone with topical Triamcinolone acetonide (0.1%).

Results: Group 2 in which oral Dapsone and topical Tacrolimus (0.1%) given showed the best results i.e. good response shown by 45.45% patients and excellent response shown by 36.36% patients without any major side effects.

Conclusions: The study showed that Dapsone in combination with topical Tacrolimus ointment (0.1%) is safe, well tolerated, and effective therapy for OLP


Keywords

Dapsone, Oral Lichen Planus, Topical Therapy, Tacrolimus Ointment, Triamcinolone Acetonide
Subscription Login to verify subscription
User
Notifications
Font Size


  • Gorouhi F, Solhpour A, Beitoahi JM, Afshar S, Davari P, Hasheni P,Nassiri KM Firooz: A Randomized trial of pimecrolimus cream versus Triamcinolone acetonide paste in the treatment of oral Lichen Planus .J Am Acad .Dermatol 2007; 57(5)806.

  • Albrecht M, Banoezy J. Occurrence of Oral Leukoplakia & Lichen Planus in Diabetes Mellitus. J Oral Pathol Med 1992, 21:364-66.

  • Persiæ S, Mihie LL, Budimir J, Situm M, Bulatz V, Krolo I. Oral lesions in patients with lichen planus. Acta Clin Croat. 2008;47(2):9

  • Philip Sugerman, Stephen R Porter, Oral LichenPlanus. http://emedicine.medscape.com/ article/1078327-overview,2009

  • Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases: selective review of the literature. Oral Surg Oral Med Oral Pathol 1994;77:555-71

  • Glick M, Greenberg M. Burket’s Oral Medicine: Diagnosis and Treatment, 10th ed. Hamilton: BC Decker Inc; 2003:107-110

  • Falk DK, Latour DL, King LE. Dapsone in the treatment of erosive lichen planus. J Am Acad Dermatol 1985;12:567

  • Beck HI, Flemming B. Treatment of erosive lichen planus with dapsone. Acta Derm. Venereol (Stockh) 1986;366-367.

  • Kumar B, Kaur I, Sharma VK. Efficacy of dapsone in lichen planus. Indian J Dermatol Venereol Leprol 1989;55:164-166.

  • Kumar V, Garg BR, Baruah MC, et al. Childhood lichen planus. Dermatol 1993;20:175-177.

  • Radfar L, Wild RC, Suresh L. A Comparative treatment study of topical tacrolimus and clobetasol in Oral Lichen Planus. Oral Surg Oral Med Oral path Oral Radiol Endod 2008;105(2),187-93.

  • Byrd JA, Davis MD, Rogers RS .Response of Oral Lichen Planus to topical tacrolimus in 37 patients. J Arch Dermatol 2004;1: 508-12.

  • Buajeeb W, Kraisapan P .Efficacy of topical retionoic acidcompared with topical fluocinolone acetonide in the treatmentof Oral Lichen Planus. Oral Surg, Oral Med Oral Pathol OralRadiol Endod 1997; 83,21-25.

  • Rozycki TW, Rogers RS. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 2002; 46:27-34.

  • Morrison L, Gorman A. An open trial of topic tacrolimus for erosive lichen planus. J Am Acad Dermatol 2002; 47:617-620.

  • Byrd JA, Davis MD, Rogers RS. Response of oral lichen planus to topical tocrolimus in 37 patients. J Arch Dermatol 2004;140:1508-12.

  • Riano A, Martino R, glesias ME, Garatea J. Topical tacrolimus, alternative treatment for oral erosive lichen planus resistant to steroids. J Med Oral Patol Oral Cir Buccal 2006;11:462-6.

  • Passeron T, Laccour JP, Fontas E, Ortonne JP. Treatment of oral erosive lichen planus with pimecrolimus cream. A double-blind, randomized prospective trial with measurement of pimecrolimus level in the blood. J Arch Dermatol 2007;143:472-6.

  • Stendahl O, Mobin L, Dahlgren C. The inhibition of polymorphonuclear toxicity by dapsone. J Clin Invest 1998;62:214-220.

  • Ruzicka T, Wasserman SI, Soter NA, et al. Inhibition of rat mast cell arachidonic acid cyclo-oxygenase by dapsone J Allergy Clin Immunol 1983;72: 365-370.

  • Beigueltnan B, Pisani RCB. Effect of DDS on phytohae-magglutinin induced lymphocyte transformation. Int J Lepr 1974;42:412-415.

  • Ruzicka T, Assmann T, Homey B. Tacrolimus: the drug for the turn of the millennium Arch Dermatol 1999;135:574-580.

  • Cooper KD. Atopic Dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102:128-137.

  • Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46: 228-41.

  • Pederson AK, Lausen B. Glucocorticosteroid therapy and oral medicine. J Oral Pathol Med 1984;13:1-15.


Abstract Views: 333

PDF Views: 0




  • Comparative Study of the Therapeutic Efficacy of the Dapsone (Alone), Dapsone Plus Tacrolimus (Topical) and Dapsone Plus Triamcinolone (Topical) in Oral Lichen Planus

Abstract Views: 333  |  PDF Views: 0

Authors

Sachin Agarwal
Department of Dermatology, Santosh Medical College, Ghaziabad (UP), India
Geeta Gupta
Department of Microbiology, Santosh Medical College, Ghaziabad (UP), India
S. K. Sayal
Department of Dermatology, Santosh Medical College, Ghaziabad (UP), India

Abstract


Background: Oral lichen planus (OLP) is a common, chronic inflammatory condition, which frequently present with symptoms of pain and irritation. OLP is difficult to manage. Existing clinical trials have shown that oral Dapsone and topical corticosteroids are often effective in the management of OLP. However, Tacrolimus has recently been shown to be an effective treatment of OLP without any side effects.

Objective: The purpose of this study was to compare the efficacy and safety of Dapsone (alone), Dapsone + Tacrolimus (topical) and Dapsone +Triamcinolone (topical) in management of OLP. Material and Method: In this randomized comparative double-blind study, 57 patients with oral lesions consistent clinically and histologically with OLP were recruited. Patients were divided into three groups of 17 and 22 & 18. In group-1, 17 patients were given oral Dapsone alone. In group-2, 22 patients were given oral Dapsone and topical Tacrolimus (0.1%).while in group 3, 18 patients were given oral Dapsone with topical Triamcinolone acetonide (0.1%).

Results: Group 2 in which oral Dapsone and topical Tacrolimus (0.1%) given showed the best results i.e. good response shown by 45.45% patients and excellent response shown by 36.36% patients without any major side effects.

Conclusions: The study showed that Dapsone in combination with topical Tacrolimus ointment (0.1%) is safe, well tolerated, and effective therapy for OLP


Keywords


Dapsone, Oral Lichen Planus, Topical Therapy, Tacrolimus Ointment, Triamcinolone Acetonide

References